id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2019-P-6045-0021,FDA,FDA-2019-P-6045,Final Response Letter from FDA CFSAN to Hyman Phelps and McNamara PC,Other,Response(s),2022-04-27T04:00:00Z,2022,4,2022-04-27T04:00:00Z,,2022-04-27T14:10:06Z,,0,0,0900006485039ba1
FDA-2019-P-6045-0019,FDA,FDA-2019-P-6045,180-day Interim Response to the Wacker Chemical Corporation,Other,Letter(s),2020-06-12T04:00:00Z,2020,6,2020-06-12T04:00:00Z,,2022-01-27T02:00:27Z,,0,0,09000064846ea0f7
FDA-2019-P-6045-0017,FDA,FDA-2019-P-6045,"Appendix A and B from Hyman, Phelps and McNamara, P.C. on behalf of Wacker Chemical Corporation",Supporting & Related Material,Background Material,2020-02-03T05:00:00Z,2020,2,,,2020-02-03T16:07:56Z,,0,0,0900006484321903
FDA-2019-P-6045-0016,FDA,FDA-2019-P-6045,"Cover letter from Hyman, Phelps and McNamara, P.C. on behalf of Wacker Chemical Corporation",Supporting & Related Material,Background Material,2020-02-03T05:00:00Z,2020,2,,,2020-02-03T16:08:11Z,,0,0,0900006484321902
FDA-2019-P-6045-0018,FDA,FDA-2019-P-6045,"Alpha-Cyclodextrin Attenuates the Glycemic and Insulinemic Impact of White Bread in Healthy Male Volunteers from Hyman, Phelps and McNamara, P.C. on behalf of Wacker Chemical Corporation",Supporting & Related Material,Background Material,2020-02-03T05:00:00Z,2020,2,,,2020-02-03T16:07:44Z,,0,0,0900006484321904
FDA-2019-P-6045-0010,FDA,FDA-2019-P-6045,"Attachment 8 Koukiekolo R., et al (2001) re Citizen Petition from Hyman, Phelps and McNamara, P.C. on behalf of Wacker Chemical Corporation",Supporting & Related Material,Background Material,2019-12-27T05:00:00Z,2019,12,,,2019-12-27T17:49:42Z,,0,0,0900006484251ef0
FDA-2019-P-6045-0002,FDA,FDA-2019-P-6045,"Acknowledgment Letter from FDA DMS to Hyman, Phelps and McNamara, P.C.",Other,Acknowledgement Letter/Receipt,2019-12-27T05:00:00Z,2019,12,2019-12-27T05:00:00Z,,2019-12-27T17:20:01Z,,0,0,09000064842518e7
FDA-2019-P-6045-0004,FDA,FDA-2019-P-6045,"Attachment 2 Diamantis I., et al (2019). re Citizen Petition from Hyman, Phelps and McNamara, P.C. on behalf of Wacker Chemical Corporation",Supporting & Related Material,Background Material,2019-12-27T05:00:00Z,2019,12,,,2019-12-27T17:47:38Z,,0,0,0900006484251ab1
FDA-2019-P-6045-0007,FDA,FDA-2019-P-6045,"Attachment 5 Gentilcore D., et al (2011) re Citizen Petition from Hyman, Phelps and McNamara, P.C. on behalf of Wacker Chemical Corporation",Supporting & Related Material,Background Material,2019-12-27T05:00:00Z,2019,12,,,2019-12-27T17:48:44Z,,0,0,0900006484251b7e
FDA-2019-P-6045-0015,FDA,FDA-2019-P-6045,"Attachment 13 Van Ommen B., et al (2004) re Citizen Petition from Hyman, Phelps and McNamara, P.C. on behalf of Wacker Chemical Corporation",Supporting & Related Material,Background Material,2019-12-27T05:00:00Z,2019,12,,,2019-12-27T17:51:51Z,,0,0,0900006484251ef5
FDA-2019-P-6045-0006,FDA,FDA-2019-P-6045,"Attachment 4 Fletcher (2013) re Citizen Petition from Hyman, Phelps and McNamara, P.C. on behalf of Wacker Chemical Corporation",Supporting & Related Material,Background Material,2019-12-27T05:00:00Z,2019,12,,,2019-12-27T17:48:10Z,,0,0,0900006484251b7d
FDA-2019-P-6045-0011,FDA,FDA-2019-P-6045,"Attachment 9 Lightowler H., et al (2018) re Citizen Petition from Hyman, Phelps and McNamara, P.C. on behalf of Wacker Chemical Corporation",Supporting & Related Material,Background Material,2019-12-27T05:00:00Z,2019,12,,,2019-12-27T17:50:08Z,,0,0,0900006484251ef1
FDA-2019-P-6045-0005,FDA,FDA-2019-P-6045,"Attachment 3  EFSA (2012) re Citizen Petition from Hyman, Phelps and McNamara, P.C. on behalf of Wacker Chemical Corporation",Supporting & Related Material,Background Material,2019-12-27T05:00:00Z,2019,12,,,2019-12-27T17:47:54Z,,0,0,0900006484251b7c
FDA-2019-P-6045-0012,FDA,FDA-2019-P-6045,"Attachment 10 McCleary B.V., et al (2004) re Citizen Petition from Hyman, Phelps and McNamara, P.C. on behalf of Wacker Chemical Corporation",Supporting & Related Material,Background Material,2019-12-27T05:00:00Z,2019,12,,,2019-12-27T17:50:33Z,,0,0,0900006484251ef2
FDA-2019-P-6045-0008,FDA,FDA-2019-P-6045,"Attachment 6 Jarosz P.A., et al (2013) re Citizen Petition from Hyman, Phelps and McNamara, P.C. on behalf of Wacker Chemical Corporation",Supporting & Related Material,Background Material,2019-12-27T05:00:00Z,2019,12,,,2019-12-27T17:48:58Z,,0,0,0900006484251b7f
FDA-2019-P-6045-0009,FDA,FDA-2019-P-6045,"Attachment 7 Kondo, H., et al (1990) re Citizen Petition from Hyman, Phelps and McNamara, P.C. on behalf of Wacker Chemical Corporation",Supporting & Related Material,Background Material,2019-12-27T05:00:00Z,2019,12,,,2019-12-27T17:49:25Z,,0,0,0900006484251eef
FDA-2019-P-6045-0003,FDA,FDA-2019-P-6045,"Attachment 1 Buckley J.D., et al (2006) re Citizen Petition from Hyman, Phelps and McNamara, P.C. on behalf of Wacker Chemical Corporation",Supporting & Related Material,Background Material,2019-12-27T05:00:00Z,2019,12,,,2019-12-27T17:47:18Z,,0,0,09000064842518ec
FDA-2019-P-6045-0013,FDA,FDA-2019-P-6045,"Attachment 11 Oudjeriouat N.,et al (2003) re Citizen Petition from Hyman, Phelps and McNamara, P.C. on behalf of Wacker Chemical Corporation",Supporting & Related Material,Background Material,2019-12-27T05:00:00Z,2019,12,,,2019-12-27T17:51:18Z,,0,0,0900006484251ef3
FDA-2019-P-6045-0001,FDA,FDA-2019-P-6045,"Citizen Petition from Hyman, Phelps and McNamara, P.C. on behalf of Wacker Chemical Corporation",Other,Citizen Petition,2019-12-27T05:00:00Z,2019,12,2019-12-27T05:00:00Z,,2022-04-27T14:03:34Z,,0,0,0900006484250c64
FDA-2019-P-6045-0014,FDA,FDA-2019-P-6045,"Attachment 12 Sugahara M., et al (2016) re Citizen Petition from Hyman, Phelps and McNamara, P.C. on behalf of Wacker Chemical Corporation",Supporting & Related Material,Background Material,2019-12-27T05:00:00Z,2019,12,,,2019-12-27T17:51:35Z,,0,0,0900006484251ef4